Immediate test results and patient treatment reduces the likelihood of a readmission “within 30 days of discharge” that could result in hospital penalties under Accountable Care.
“Consolidates and replaces a suitcase full of readers with a single device, that adapts to existing and FDA Cleared Point of Care tests, eliminates transportation of patient samples to central labs by testing the patient wherever they are, and transmits test results directly to The Cloud. The device that finally makes Point of Care diagnostics practical for healthcare providers."
iAssay has benefitted from this trend as predicted years ago. Our equity raise and increasing revenues prove it. The whole story from The Wall Street Journal– Increasing venture-capital investment in digital health is helping startups accelerate their growth while also raising concerns that the market is overheating. Venture investors pumped $14.7 billion into digital-health startups […]
SimpleTest™ by iAssay will be closing its Wefunder campaign ( www.WeFunder.com/iAssay ) in 2 days. The response to our recent announcement that within 18 months we will bring SimpleTest™, a device used by healthcare professionals, directly to consumer homes has been overwhelming. The opportunity for growth has exploded and we are excited to be giving you […]
Murrieta & San Diego, California USA, & Taipei City Taiwan — June 22, 2021 — From Athos, Porthos and Aramis to Luke, Leia and Han, something magical happens when three unique and powerful forces unite. Today, a trio of cutting-edge companies announced a global collaboration that will enable nearly instant medical test results, bypassing traditional biological […]
SimpleTest™ by iAssay will be closing our Wefunder campaign in 2 weeks. Your chance to get in on the ground floor of this revolutionary healthcare device is coming to a close. www.WeFunder.com/iAssay .iAssay, a pioneer in medical device technology, has developed a patented diagnostic tool, SimpleTest™, that has already begun to revolutionize the Healthcare industry through Point […]
Thank you to everyone who attended our Investor Webinar. This was a great opportunity to meet more of the iAssay team, hear about some of our recent highlights and have your questions answered. If you were unable to join we don’t want you to miss out! As a supporter of iAssay, we are pleased to […]
SimpleTest™ by iAssay is the only universal, portable medical test reader on the market, and is poised to radically improve patient health. At our upcoming webinar, iAssay will be presenting an in-depth look at how SimpleTest™ has already begun to revolutionize the $26 Billion Medical Testing industry and the $65 Billion Healthcare Big Data industry. […]
We are so excited to be a part of an exclusive group of companies who have been named a COOL Company for the 2nd consecutive year. The COOL Companies list identifies San Diego’s fastest growing and most exciting companies; put together by Connect, which pairs tech and life science companies with quality capital and mentorship. […]
We are pleased to announce that SimpleTest™ by iAssay has over 100 investors. This is an incredible achievement for us as a company and we want to thank everyone who believes in our mission. It is thanks to you that we will be able to revolutionize the healthcare industry and help millions of people to […]
Innovative Program Aims to Improve Medical Testing Capabilities San Diego, CA 04/29/2021- iAssay announced this week that they have been awarded a Phase 1 SBIR (Small Business Innovation Research) Award through AFWERX. iAssay makes a patent-protected medical device called SimpleTest™ that can interpret test results and transmit preserved imaging and quantitative results electronically from point of […]